User's Publication |
21711
Yusuke Hanaki, Rintaro Abe, Yasunori Sugiyama, Yasumasa Hara, Ryo C. Yanagita
A new labdane-type diterpenoid from leaves of Vitex rotundifolia
Results in Chemistry
2024
7:101512
DOI: 10.1016/j.rechem.2024.101512
|
18065
Yusuke Hanaki, Nichika Iwase, Yasunori Sugiyama, Sena Miyoshi, Ryo C. Yanagita
Cell Morphology-Based Screening Identified Vitetrifolin D from Vitex Rotundifolia as an Inhibitor of Phorbol Ester–Induced Downregulation of E-Cadherin in HHUA Endometrial Cells
BPB Reports
2023
6:103-107
DOI: 10.1248/bpbreports.6.3_103
|
18120
Bai H, Kawahara M, Takahashi M.
Identification of menaquinone-4 (vitamin K2) target genes in bovine endometrial epithelial cells in vitro
Theriogenology
2023
198:183-193
PubMed ID: 36592516
DOI: 10.1016/j.theriogenology.2022.12.033
|
17618
Dong P, Wang F, Taheri M, Xiong Y, Ihira K, Kobayashi N, Konno Y, Yue J, Watari H.
Long Non-Coding RNA TMPO-AS1 Promotes GLUT1-Mediated Glycolysis and Paclitaxel Resistance in Endometrial Cancer Cells by Interacting With miR-140 and miR-143
Front Oncol
2022
12:912935
PubMed ID: 35712514
DOI: 10.3389/fonc.2022.912935
|
20554
Sendo K, Seino M, Ohta T, Nagase S.
Impact of the glutathione synthesis pathway on sulfasalazine-treated endometrial cancer.
Oncotarget
2022
13:224-236
PubMed ID: 35106124
DOI: 10.18632/oncotarget.28185
|
20722
Takao T, Masuda H, Kajitani T, Miki F, Miyazaki K, Yoshimasa Y, Katakura S, Tomisato S, Uchida S, Uchida H, Tanaka M, Maruyama T.
Sorafenib targets and inhibits the oncogenic properties of endometrial cancer stem cells via the RAF/ERK pathway.
Stem Cell Res Ther
2022
13(1):225
PubMed ID: 35659728
DOI: 10.1186/s13287-022-02888-y
|
17174
Hanaki Y, Miyoshi S, Sugiyama Y, Yanagita RC, Sato M.
12-O-Tetradecanoylphorbol 13-acetate promotes proliferation and epithelial-mesenchymal transition in HHUA cells cultured on collagen type I gel: A feasible model to find new therapies for endometrial diseases
Biosci Biotechnol Biochem
2022
86(10):1417-1422
PubMed ID: 35973688
DOI: 10.1093/bbb/zbac136
|
13789
Kojima M, Sugimoto K, Kobayashi M, Ichikawa-Tomikawa N, Kashiwagi K, Watanabe T, Soeda S, Fujimori K, Chiba H.
Aberrant claudin-6-adhesion signaling promotes endometrial cancer progression via estrogen receptor α
Mol Cancer Res
2021
molcanres.0835.2020
PubMed ID: 33727343
DOI: 10.1158/1541-7786.MCR-20-0835
|
14469
Yusuke Hanaki, Yusuke Araki, Toshio Nishikawa, Ryo C. Yanagita
Evaluation of the in vitro cytotoxicity of oscillatoxins E and F under nutrient-starvation culture conditions
Fundamental Toxicological Sciences
2021
8:69-73
DOI: 10.2131/fts.8.69
|
20209
Dong P, Xiong Y, Konno Y, Ihira K, Kobayashi N, Yue J, Watari H.
Long non-coding RNA DLEU2 drives EMT and glycolysis in endometrial cancer through HK2 by competitively binding with miR-455 and by modulating the EZH2/miR-181a pathway.
J Exp Clin Cancer Res
2021
40(1):216
PubMed ID: 34174908
DOI: 10.1186/s13046-021-02018-1
|
13321
Kato M, Onoyama I, Kawakami M, Yoshida S, Kawamura K, Kodama K, Hori E, Cui L, Matsumura Y, Yagi H, Asanoma K, Yahata H, Itakura A, Takeda S, Kato K.
Downregulation of 5-hydroxymethylcytosine is associated with the progression of cervical intraepithelial neoplasia.
PLoS One
2020
PubMed ID: 33141854
DOI: 10.1371/journal.pone.0241482
|
13779
Kato M, Onoyama I, Yoshida S, Cui L, Kawamura K, Kodama K, Hori E, Matsumura Y, Yagi H, Asanoma K, Yahata H, Itakura A, Takeda S, Kato K.
Dual-specificity phosphatase 6 plays a critical role in the maintenance of a cancer stem-like cell phenotype in human endometrial cancer
Int J Cancer
2020
147(7):1987-1999
PubMed ID: 32159851
DOI: 10.1002/ijc.32965
|
10248
Osanai K, Kobayashi Y, Otsu M, Izawa T, Sakai K, Iwashita M.
Ramelteon, a selective MT1/MT2 receptor agonist, suppresses the proliferation and invasiveness of endometrial cancer cells.
Hum. Cell
2017
30:209-215
PubMed ID: 28382516
DOI: 10.1007/s13577-017-0169-7
|
10315
Ando H, Miyamoto T, Kashima H, Higuchi S, Ida K, Mvunta DH, Shiozawa T.
Panobinostat Enhances Growth Suppressive Effects of Progestin on Endometrial Carcinoma by Increasing Progesterone Receptor and Mitogen-Inducible Gene-6.
Horm Cancer
2017
8:257-267
PubMed ID: 28516379
DOI: 10.1007/s12672-017-0295-4
|
9667
Chuwa AH, Sone K, Oda K, Ikeda Y, Fukuda T, Wada-Hiraike O, Inaba K, Makii C, Takeuchi M, Oki S, Miyasaka A, Kashiyama T, Arimoto T, Kuramoto H, Kawana K, Yano T, Osuga Y, Fujii T.
Significance of survivin as a prognostic factor and a therapeutic target in endometrial cancer.
Gynecol. Oncol.
2016
141:564-569
PubMed ID: 27079211
DOI: 10.1016/j.ygyno.2016.04.003
|
9687
Miyamoto T, Kashima H, Yamada Y, Kobara H, Asaka R, Ando H, Higuchi S, Ida K, Mvunta DH, Shiozawa T.
Lipocalin 2 Enhances Migration and Resistance against Cisplatin in Endometrial Carcinoma Cells.
PLoS ONE
2016
11:e0155220
PubMed ID: 27168162
DOI: 10.1371/journal.pone.0155220
|
12617
Nakayama K, Rahman MT, Rahman M, Nakamura K, Ishikawa M, Katagiri H, Sato E, Ishibashi T, Iida K, Ishikawa N, Kyo S.
CCNE1 amplification is associated with aggressive potential in endometrioid endometrial carcinomas
Int J Oncol
2016
48(2):506-16
PubMed ID: 26647729
DOI: 10.3892/ijo.2015.3268
|
12648
Zou J, Hong L, Luo C, Li Z, Zhu Y, Huang T, Zhang Y, Yuan H, Hu Y, Wen T, Zhuang W, Cai B, Zhang X, Huang J, Cheng J.
Metformin inhibits estrogen-dependent endometrial cancer cell growth by activating the AMPK-FOXO1 signal pathway
Cancer Sci
2016
107(12):1806-1817
PubMed ID: 27636742
DOI: 10.1111/cas.13083
|
7200
Asanoma K, Liu G, Yamane T, Miyanari Y, Takao T, Yagi H, Ohgami T, Ichinoe A, Sonoda K, Wake N, Kato K.
Regulation of the Mechanism of TWIST1 Transcription by BHLHE40 and BHLHE41 in Cancer Cells.
Mol. Cell. Biol.
2015
35:4096-109
PubMed ID: 26391953
DOI: 10.1128/MCB.00678-15
|
7212
Asaka R, Miyamoto T, Yamada Y, Ando H, Mvunta DH, Kobara H, Shiozawa T.
Sirtuin 1 promotes the growth and cisplatin resistance of endometrial carcinoma cells: a novel therapeutic target.
Lab. Invest.
2015
95:1363-73
PubMed ID: 26367491
DOI: 10.1038/labinvest.2015.119
|
13788
Kajitani K, Honda K, Terada H, Yasui T, Sumi T, Koyama M, Ishiko O.
Human Papillomavirus E6 Knockdown Restores Adenovirus Mediated-estrogen Response Element Linked p53 Gene Transfer in HeLa Cells
Asian Pac J Cancer Prev
2015
16(18):8239-45
PubMed ID: 26745067
DOI: 10.7314/apjcp.2015.16.18.8239
|
18133
Dong P, Kaneuchi M, Xiong Y, Cao L, Cai M, Liu X, Guo SW, Ju J, Jia N, Konno Y, Watari H, Hosaka M, Sudo S, Sakuragi N.
Identification of KLF17 as a novel epithelial to mesenchymal transition inducer via direct activation of TWIST1 in endometrioid endometrial cancer
Carcinogenesis
2014
35(4):760-8
PubMed ID: 24220291
DOI: 10.1093/carcin/bgt369
|
13796
Koyama N, Nishida Y, Ishii T, Yoshida T, Furukawa Y, Narahara H.
Telmisartan induces growth inhibition, DNA double-strand breaks and apoptosis in human endometrial cancer cells
PLoS One
2014
9(3):e93050
PubMed ID: 24667764
DOI: 10.1371/journal.pone.0093050
|
13828
Miyasaka A, Oda K, Ikeda Y, Wada-Hiraike O, Kashiyama T, Enomoto A, Hosoya N, Koso T, Fukuda T, Inaba K, Sone K, Uehara Y, Kurikawa R, Nagasaka K, Matsumoto Y, Arimoto T, Nakagawa S, Kuramoto H, Miyagawa K, Yano T, Kawana K, Osuga Y, Fujii T.
Anti-tumor activity of olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, in cultured endometrial carcinoma cells
BMC Cancer
2014
14:179
PubMed ID: 24625059
DOI: 10.1186/1471-2407-14-179
|
18134
Dong P, Karaayvaz M, Jia N, Kaneuchi M, Hamada J, Watari H, Sudo S, Ju J, Sakuragi N.
Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis
Oncogene
2013
32(27):3286-95
PubMed ID: 22847613
DOI: 10.1038/onc.2012.334
|
6463
Li H, Narahara H.
15-Deoxy-Δ(12,14)-prostaglandin J(2) induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer cell lines.
Int J Mol Med.
2013
31(4):778-88
PubMed ID: 23403520
DOI: 10.3892/ijmm.2013.1268
|
13830
Ishii T, Kira N, Yoshida T, Narahara H.
Cucurbitacin D induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial and ovarian cancer cells
Tumour Biol
2013
34(1):285-91
PubMed ID: 23150173
DOI: 10.1007/s13277-012-0549-2
|
7588
Mitsuhashi Y, Horiuchi A, Miyamoto T, Kashima H, Suzuki A, Shiozawa T.
Prognostic significance of Notch signalling molecules and their involvement in the invasiveness of endometrial carcinoma cells.
Histopathology
2012
60:826-37
PubMed ID: 22348356
DOI: 10.1111/j.1365-2559.2011.04158.x
|
13801
Tanaka T, Bai T, Toujima S, Utsunomiya T, Utsunomiya H, Yukawa K, Tanaka J.
Impaired death-associated protein kinase-mediated survival signals in 5-fluorouracil-resistant human endometrial adenocarcinoma cells
Oncol Rep
2012
28(1):330-6
PubMed ID: 22552543
DOI: 10.3892/or.2012.1774
|
18135
Tsuruta T, Kozaki K, Uesugi A, Furuta M, Hirasawa A, Imoto I, Susumu N, Aoki D, Inazawa J.
miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer
Cancer Res
2011
71(20):6450-62
PubMed ID: 21868754
DOI: 10.1158/0008-5472.CAN-11-0364
|
7708
Dong P, Kaneuchi M, Watari H, Hamada J, Sudo S, Ju J, Sakuragi N.
MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1.
Mol. Cancer
2011
10:99
PubMed ID: 21851624
DOI: 10.1186/1476-4598-10-99
|
7925
Miyamoto T, Kashima H, Suzuki A, Kikuchi N, Konishi I, Seki N, Shiozawa T.
Laser-captured microdissection-microarray analysis of the genes involved in endometrial carcinogenesis: stepwise up-regulation of lipocalin2 expression in normal and neoplastic endometria and its functional relevance.
Hum. Pathol.
2011
42:1265-74
PubMed ID: 21334721
DOI: 10.1016/j.humpath.2010.07.027
|
13786
Honda K, Kajitani K, Nobeyama H, Kira Y, Yabunaka Y, Egami M, Zhi X, Fukuda T, Yoshida H, Matsumoto Y, Ichimura T, Yaui T, Sumi T, Ishiko O.
An upstream estrogen response element linked to exogenous p53 tumor suppressor gene expression differentiates effects of the codon 72 polymorphism
Asian Pac J Cancer Prev
2011
12(4):865-8
PubMed ID: 21790217
|
13815
Tanaka T, Bai T, Yukawa K.
Specific downregulation of death-associated protein kinase enhances Fas-mediated apoptosis in the human differentiated endometrial adenocarcinoma cell line, HHUA
Eur J Gynaecol Oncol
2011
32(3):293-6
PubMed ID: 21797120
|
13821
Tanaka T, Bai T, Utsunomiya H, Fukumoto T, Yukawa K.
STAT3 enhances intracellular Fas-mediated apoptotic signals in HHUA human endometrial epithelial cells
Mol Med Rep
2011
4(2):307-12
PubMed ID: 21468569
DOI: 10.3892/mmr.2011.424
|
8350
Fakhry H, Miyamoto T, Kashima H, Suzuki A, Ke H, Konishi I, Shiozawa T.
Immunohistochemical detection of histone deacetylases in endometrial carcinoma: involvement of histone deacetylase 2 in the proliferation of endometrial carcinoma cells.
Hum. Pathol.
2010
41:848-58
PubMed ID: 20178884
DOI: 10.1016/j.humpath.2009.11.012
|
8539
Suzuki A, Horiuchi A, Ashida T, Miyamoto T, Kashima H, Nikaido T, Konishi I, Shiozawa T.
Cyclin A2 confers cisplatin resistance to endometrial carcinoma cells via up-regulation of an Akt-binding protein, periplakin.
J. Cell. Mol. Med.
2010
14:2305-17
PubMed ID: 19583808
DOI: 10.1111/j.1582-4934.2009.00839.x
|
13793
Bai T, Tanaka T, Yukawa K.
Targeted knockdown of death-associated protein kinase expression induces TRAIL-mediated apoptosis in human endometrial adenocarcinoma cells
Int J Oncol
2010
37(1):203-10
PubMed ID: 20514412
DOI: 10.3892/ijo_00000668
|
13794
Tanaka T, Bai T, Yukawa K.
Suppressed protein expression of the death-associated protein kinase enhances 5-fluorouracil-sensitivity but not etoposide-sensitivity in human endometrial adenocarcinoma cells
Oncol Rep
2010
24(5):1401-5
PubMed ID: 20878137
DOI: 10.3892/or_00000999
|
13827
Tanaka T, Bai T, Toujima S.
Establishment and characterization of monoclonal 5-fluorouracil-resistant cell lines derived from human endometrial adenocarcinoma
Int J Oncol
2010
37(3):731-6
PubMed ID: 20664942
DOI: 10.3892/ijo_00000722
|
13833
Takai N, Ueda T, Nishida M, Nasu K, Narahara H.
PK11195 enhances chemosensitivity to cisplatin and paclitaxel in human endometrial and ovarian cancer cells
Int J Mol Med
2010
25(1):97-103
PubMed ID: 19956907
|
13835
Takai N, Ueda T, Nishida M, Nasu K, Narahara H.
Synergistic anti-neoplastic effect of AG1478 in combination with cisplatin or paclitaxel on human endometrial and ovarian cancer cells
Mol Med Rep
2010
3(3):479-84
PubMed ID: 21472266
DOI: 10.3892/mmr_00000284
|
14016
Ishikawa M, Nakayama K, Yeasmin S, Katagiri A, Iida K, Nakayama N, Miyazaki K.
NAC1, a potential stem cell pluripotency factor expression in normal endometrium, endometrial hyperplasia and endometrial carcinoma
Int J Oncol
2010
36(5):1097-103
PubMed ID: 20372782
DOI: 10.3892/ijo_00000591
|
14017
Tanaka T, Bai T, Yukawa K.
Death-associated protein kinase is essential for the survival of various types of uterine cancer cells
Int J Oncol
2010
37(4):1017-22
PubMed ID: 20811724
DOI: 10.3892/ijo_00000753
|
14018
Li H, Takai N, Yuge A, Furukawa Y, Tsuno A, Tsukamoto Y, Kong S, Moriyama M, Narahara H.
Novel target genes responsive to the anti-growth activity of triptolide in endometrial and ovarian cancer cells
Cancer Lett
2010
297(2):198-206
PubMed ID: 20547442
DOI: 10.1016/j.canlet.2010.05.012
|
18119
Tanaka T, Umesaki N.
Danazol enhances Fas-mediated apoptosis in human endometrial epithelial cells within normal physiology
Int J Mol Med
2009
23(2):237-43
PubMed ID: 19148548
|
18136
The oncogenic mutation in the pleckstrin homology domain of AKT1 in endometrial carcinomas
The oncogenic mutation in the pleckstrin homology domain of AKT1 in endometrial carcinomas
Br J Cancer
2009
101(1):145-8.
PubMed ID: 19491896
DOI: 10.1038/sj.bjc.6605109
|
13787
Ishibashi M, Nakayama K, Yeasmin S, Katagiri A, Iida K, Nakayama N, Miyazaki K.
Expression of a BTB/POZ protein, NAC1, is essential for the proliferation of normal cyclic endometrial glandular cells and is up-regulated by estrogen
Clin Cancer Res
2009
15(3):804-11
PubMed ID: 19188150
DOI: 10.1158/1078-0432.CCR-08-2134
|
13803
Takai N, Ueda T, Nasu K, Yamashita S, Toyofuku M, Narahara H.
Targeting calcium/calmodulin-dependence kinase I and II as a potential anti-proliferation remedy for endometrial carcinomas
Cancer Lett
2009
277(2):235-43
PubMed ID: 19168280
DOI: 10.1016/j.canlet.2008.12.018
|
13822
Tanaka T, Wang C, Umesaki N.
Remodeling of the human endometrial epithelium is regulated by laminin and type IV collagen
Int J Mol Med
2009
23(2):173-80
PubMed ID: 19148540
|
8749
Matsumoto M, Yamaguchi Y, Seino Y, Hatakeyama A, Takei H, Niikura H, Ito K, Suzuki T, Sasano H, Yaegashi N, Hayashi S.
Estrogen signaling ability in human endometrial cancer through the cancer-stromal interaction.
Endocr. Relat. Cancer
2008
15:451-63
PubMed ID: 18508998
DOI: 10.1677/ERC-07-0227
|
13798
Yoshizaki T, Enomoto T, Fujita M, Ueda Y, Miyatake T, Fujiwara K, Miyake T, Kimura T, Yoshino K, Kimura T.
Frequent inactivation of RUNX3 in endometrial carcinoma
Gynecol Oncol
2008
110(3):439-44
PubMed ID: 18572225
DOI: 10.1016/j.ygyno.2008.05.004
|
13823
Tanaka T, Umesaki N.
Leptin regulates the proliferation and apoptosis of human endometrial epithelial cells
Int J Mol Med
2008
22(5):683-9.
PubMed ID: 18949391
|
13829
Takai N, Ueda T, Nishida M, Nasu K, Narahara H.
Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells
Int J Mol Med
2008
21(5):637-43
PubMed ID: 18425357
|
13834
Takai N, Ueda T, Nishida M, Nasu K, Narahara H.
K252a is highly effective in suppressing the growth of human endometrial cancer cells, but has little effect on normal human endometrial epithelial cells
Oncol Rep
2008
19(3):749-53
PubMed ID: 18288411
|
18130
Feng YZ, Shiozawa T, Miyamoto T, Kashima H, Kurai M, Suzuki A, Ying-Song J, Konishi I.
Overexpression of hedgehog signaling molecules and its involvement in the proliferation of endometrial carcinoma cells
Clin Cancer Res
2007
13(5):1389-98
PubMed ID: 17332280
DOI: 10.1158/1078-0432.CCR-06-1407
|
18131
Sato N, Ito K, Onogawa T, Akahira J, Unno M, Abe T, Niikura H, Yaegashi N.
Expression of organic cation transporter SLC22A16 in human endometria
Int J Gynecol Pathol
2007
26(1):53-60
PubMed ID: 17197897
DOI: 10.1097/01.pgp.0000225845.67245.b3
|
8772
Sugimoto T, Koizumi T, Sudo T, Yamaguchi S, Kojima A, Kumagai S, Nishimura R.
Correlative expression of cyclooxygenase-1 (Cox-1) and human epidermal growth factor receptor type-2 (Her-2) in endometrial cancer.
Kobe J Med Sci
2007
53:177-87
PubMed ID: 18204294
|
13785
Zhi X, Honda K, Sumi T, Yasui T, Nobeyama H, Yoshida H, Ishiko O.
Estradiol-17beta regulates vascular endothelial growth factor and Bcl-2 expression in HHUA cells
Int J Oncol
2007
31(6):1333-8
PubMed ID: 17982659
|
18617
Takai N, Ueda T, Nishida M, Nasu K, Narahara H.
Anticancer activity of MS-275, a novel histone deacetylase inhibitor, against human endometrial cancer cells
Anticancer Res
2006
26(2A):939-45
PubMed ID: 16619490
|
13790
Abe H, Shibata MA, Otsuki Y.
Caspase cascade of Fas-mediated apoptosis in human normal endometrium and endometrial carcinoma cells
Mol Hum Reprod
2006
12(9):535-41
PubMed ID: 16870953
DOI: 10.1093/molehr/gah260
|
13820
Mochizuki T, Sakai K, Iwashita M.
Effects of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) on endometrial cancer (HHUA) cell apoptosis and EGF stimulated cell proliferation in vitro
Growth Horm IGF Res
2006
16(3):202-10
PubMed ID: 16844395
DOI: 10.1016/j.ghir.2006.05.002
|
3713
Taniguchi H, Yamamoto H, Hirata T, Miyamoto N, Oki M, Nosho K, Adachi Y, Endo T, Imai K, Shinomura Y.
Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.
Oncogene
2005
24(53):7946-52
PubMed ID: 16007117
DOI: 10.1038/sj.onc.1208910
|
11007
Tetsuji Tanaka , Tao Bai, Kazunori Yukawa, Naohiko Umesaki
Radiation-induced cell death is independent of the apoptotic signals mediated by death-associated protein kinase in human cervical squamous cell carcinoma cells
Oncol Rep
2005
14(4):949-55
PubMed ID: 16142356
|
13825
Tanaka T.
Effects of anti-endometriotic therapies on Fas-mediated endometrial epithelial apoptosis
Oncol Rep
2005
13(6):1235-9
PubMed ID: 15870948
|
13795
Sugawara T, Nomura E, Fujimoto S.
Expression of enzyme associated with steroid hormone synthesis and local production of steroid hormone in endometrial carcinoma cells
J Endocrinol
2004
180(1):135-44
PubMed ID: 14709152
DOI: 10.1677/joe.0.1800135
|
13799
Enomoto M, Endo D, Kawashima S, Park MK.
Human type II GnRH receptor mediates effects of GnRH on cell proliferation
Zoolog Sci
2004
21(7):763-70
PubMed ID: 15277720
DOI: 10.2108/zsj.21.763
|
13800
Enomoto M, Seong JY, Kawashima S, Park MK.
Proliferation of TSU-Pr1, a human prostatic carcinoma cell line is stimulated by gonadotropin-releasing hormone
Life Sci . 2004 May 7;74(25):3141-52
2004
74(25):3141-52
PubMed ID: 15081579
DOI: 10.1016/j.lfs.2003.11.009
|
13826
Bai T, Tanaka T, Yukawa K, Maeda M, Umesaki N.
Reduced expression of death-associated protein kinase in human uterine and ovarian carcinoma cells
Oncol Rep
2004
11(3):661-5.
PubMed ID: 14767518
|
14020
Tanaka T, Toujima S, Umesaki N.
Activin A inhibits growth-inhibitory signals by TGF-beta1 in differentiated human endometrial adenocarcinoma cells
Oncol Rep
2004
11(4):875-9
PubMed ID: 15010888
|
14021
Tanaka T, Toujima S, Umesaki N.
Growth-inhibitory signals by activin A do not affect anticancer drug-sensitivity and acquired multi-drug-resistance in human ovarian endometrioid adenocarcinoma OVK-18 cells
Oncol Rep
2004
11(3):667-71
PubMed ID: 14767519
|
13831
Unoki M, Nakamura Y.
Methylation at CpG islands in intron 1 of EGR2 confers enhancer-like activity
FEBS Lett
2003
554(1-2):67-72
PubMed ID: 14596916
DOI: 10.1016/s0014-5793(03)01092-5
|
13832
Tanaka T, Umesaki N.
Fas antigen (CD95) mediates cell survival signals to regulate functional cellular subpopulations in normal human endometrial stromal cells
Int J Mol Med
2003
11(6):757-62
PubMed ID: 12736718
|
14019
Tanaka T, Toujima S, Otani T, Minami S, Yamoto M, Umesaki N.
Expression and function of activin receptors in human endometrial adenocarcinoma cells
Int J Oncol
2003
23(3):657-63
PubMed ID: 12888901
|
2758
Harada, Hideki, Saijo, Kaoru, Watanabe, Satoru, Tsuboi, Koji, Nose, Tadao, Ishiwata, Isamu, Ohno, Tadao
Selective expansion of human natural killer cells from peripheral blood mononuclear cells by the cell line, HFWT.
Jpn J Cancer Res
2002
93:313-9
PubMed ID: 11927014
DOI: 10.1111/j.1349-7006.2002.tb02174.x
|
13797
Enomoto M, Mori T, Park M.
Influence of serum supplements in culture medium on gonadotropin-releasing hormone effects on colony formation
Life Sci
2002
71(18):2153-60
PubMed ID: 12204773
DOI: 10.1016/s0024-3205(02)02015-5
|
3101
Matsushima-Nishiu M, Unoki M, Ono K, Tsunoda T, Minaguchi T, Kuramoto H, Nishida M, Satoh T, Tanaka T, Nakamura Y
Growth and gene expression profile analyses of endometrial cancer cells expressing exogenous PTEN.
Cancer Res
2001
61:3741-9
PubMed ID: 11325847
|
13816
Enomoto M, Mori T, Park MK.
GnRH agonist Buserelin affects colony-forming efficiency of HHUA and Jurkat cells
Biochem Biophys Res Commun
2001
289(5):1180-7
PubMed ID: 11741317
DOI: 10.1006/bbrc.2001.6131
|
13792
Tanaka T, Umesaki N.
Cytokine regulation of apoptotic susceptibility in a human endometrial epithelial cell line
J Reprod Immunol
2000
47(2):105-19
PubMed ID: 10924745
DOI: 10.1016/s0165-0378(00)00062-0
|
13819
Tauchi H, Komatsu K, Ishizaki K, Yatagai F, Kato T.
Mutation spectrum of MSH3-deficient HHUA/chr.2 cells reflects in vivo activity of the MSH3 gene product in mismatch repair
Mutat Res
2000
447(2):155-64
PubMed ID: 10751599
DOI: 10.1016/s0027-5107(99)00199-2
|
13824
Tanaka T, Mizuno K, Miyama M, Chang L, Chen H, Ohtaki S, Umesaki N, Ogita S.
Enhanced Fas/CD95-mediated apoptosis by epidermal growth factor in human endometrial epithelial cells
Eur J Obstet Gynecol Reprod Biol
1999
86(2):189-94
PubMed ID: 10509790
DOI: 10.1016/s0301-2115(99)00048-2
|
14015
Kunishige I, Samejima Y, Shiki Y, Moriyama A, Meruelo D, Saji F, Murata Y.
Suicide gene therapy for human uterine adenocarcinoma cells using herpes simplex virus thymidine kinase
Gynecol Oncol
1999
72(1):16-25
PubMed ID: 9889024
DOI: 10.1006/gyno.1998.5224
|
18137
Tanaka T, Mizuno K, Umesaki N, Ogita S.
Suppressed apoptotic susceptibility in human endometrial epithelial cells pretreated with hepatocyte growth factor
Clin Exp Obstet Gynecol
1998
25(4):125-8
PubMed ID: 9987568
|
13791
Chang L, Tanaka T, Umesaki N, Ogita S.
Differential apoptotic susceptibility to anti-Fas IgM and anticancer drugs in a human endometrial adenocarcinoma cell line HHUA on laminin and type I collagen
Osaka City Med J
1998
44(2):173-80
PubMed ID: 10097597
|
13817
Tanaka T, Umesaki N, Mizuno K, Chang L, Ohtaki S, Ogita S.
Enhancement of apoptotic susceptibility by interleukin-1 beta in human endometrial epithelial cells
Gynecol Endocrinol
1998
12(5):315-9
PubMed ID: 9859023
DOI: 10.3109/09513599809012832
|
1212
T. Tanaka, N. Umesaki, K. Mizuno, L. Chang, M. Miyama, S. Ohtaki, S. Ogita
Enhancement of Apoptotic Susceptibility in Human Endometrial Epithelial Cell Line HHUA by Transforming Growth Factor-β1
Hormone and Metabolic Research
1998
30:61-65
DOI: 10.1055/s-2007-978835
|
17977
Kagami I, Mizunuma H, Miyamoto S, Ibuki Y, Uchida T.
Quantification of estrogen receptor messenger RNA by quantitative polymerase chain reaction using internal standard fragment
Biochem Biophys Res Commun
1996
228(2):358-64
PubMed ID: 8920919
DOI: 10.1006/bbrc.1996.1666
|